• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Basic Research and Clinical Application of the Growth Factor of Neurofibromatosis

Research Project

Project/Area Number 02404047
Research Category

Grant-in-Aid for General Scientific Research (A)

Allocation TypeSingle-year Grants
Research Field Dermatology
Research InstitutionGunma University

Principal Investigator

HIDEKAZU Ishikawa  Gunma University School of Medicine, Department of Dermatology, Professor, 医学部, 教授 (70008233)

Co-Investigator(Kenkyū-buntansha) HAYASHI Hiroaki  Institute of Endocrinology, Gunma University, Department of Protein Chemistry, A, 内分泌研究所, 助教授 (50008611)
HORIUCHI Ryuya  Institute of Endocrinology, Gunma University, Department of Pharmacology, Associ, 内分泌研究所, 助教授 (90008342)
OHNISHI Kazunori  Gunma University School of Medicine, Department of Dermatology, Assistant Profes, 医学部, 講師 (60176948)
ISHIKAWA Osamu  Gunma University School of Medicine, Department of Dermatology, Assistant Profes, 医学部, 講師 (90168188)
Project Period (FY) 1990 – 1991
Project Status Completed (Fiscal Year 1991)
Budget Amount *help
¥1,700,000 (Direct Cost: ¥1,700,000)
Fiscal Year 1991: ¥1,700,000 (Direct Cost: ¥1,700,000)
KeywordsGrowth factor / Neurofibroma / Neurofibromatosis / Competitive binding assay / レックリングハウゼン病 / ペプチド同定
Research Abstract

We previously found that a dialysable, low-molecular-weight factor isolated from sera of patients with neurofibromatosis enhanced the cell growth and [ ^3H] thymidine uptake of neunrofibroma-derived fibroblasts (NF cells). The factor (neurofibroma fibroblast-stimulating factor. NFSF) was purified by HPLC. The purified factor showing a DNA-synthesis stimulation effect on NF cells was specifically bounds to the cells. Then, we tentatively measured NFSF concentrations in sera of patients by a competitive binding assay technique. As a result, NFSF was clearly detected in the sera of 6 of 9 adult patients with neurofibromatosis. In contrast, the factor was not detected in the sera of 2 infantile patients with pigmented macules alone or any of 5 healthy adult controls. 1. The amount of NFSF isolated from the sera of the patients was, however, too small to determine the construction of amino acid sequence. Then we purified the NFSF from the neurofibromos. We observed NFSF-activity in gel filtration fraction of the tumor extract. 2. Further, the determination of growth-stimulating activity with NF cell ws disclosed to be difficult due to shortened lifespan of NF cells in vitro. : Colony-forming efficencies (CFEs) decreased in both NF cells and dermal fibroblasts as assay cycles progressed. However, the cumulative cell generations of NF cells were approximately half that of the dermal fibroblasts. Then we tried to find the suitable established cell lines that respond to partially purified NFSF similar to NF cells among 3T3, T98, NRK, Glioma 2 and other cells. NRK cell responded to the factor in dose dependent manner. Now, we are purifying the neurofibroma-derived NFSF, the growth activity of which is determined with NRK cell.

Report

(3 results)
  • 1991 Annual Research Report   Final Research Report Summary
  • 1990 Annual Research Report
  • Research Products

    (16 results)

All Other

All Publications (16 results)

  • [Publications] Ishikawa Osamu: "Neurofibroma-derived fibroblast-stimulating factor in the serum of patients with neurofibromatosis(von Recklinghausen's disease)." Arch DermatolRes. 277. 433-8 (1985)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Ishikawa Osamu: "A decrease in colony-forming efficiency and lifespan of neurofibroma-derived fibroblastic cells." Connective Tissue. 23. (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Yamakage Akio: "Assay of neurofibroma-stimulating factor(NFSF)in patients with neurofibromatosis.In:Tuberous sclerosis and neurofibromatosis:epidermology,pathophysiology,biology and management." Ishibashi Y,Hori Y編, 191-5 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 石川 英一: "神経線維腫由来増殖因子の分離、精製 厚生省特定疾患神経皮膚症候群調査研究班平成2年度報告書" 50-1 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 石川 英一: "神経線維腫由来増殖刺激因子の検討ーその後の進渉状況ー厚生省特定疾患神経皮膚症候群調査研究班平成3年度報告書" (1992)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Ishikawa O, Ishikawa H.: "Neurofibroma-derived fibroblast-stimulating factor in the serum of patients with neurofibromatosis (von Recklinghausen's disease)." Arch Dermatol Res. 277. 433-8 (1985)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Ishikawa O, Ishikawa H.: "A decrease in colony-forming efficiency and lifespan of neurofibroma-derived fibroblastic cells." Connective Tissue. 23. (1992)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Yamakage A, Horiuchi R, Hayashi H, Ishikawa H: "Assay of neurofibroma-stimulating factor (NFSF) in patients with neurofibromatosis." Tuberous sclerosis and neurofibromatosis : epidemiology, pathophysiology, biology and management.Elsevier Science Pubrishers B. V.191-5 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Ishikawa H, Ohnishi K, Ishikawa O.: "Separation and purification of neurofibroma-derived growth factor." Annual Report of the Ministry of Health and Welfare Neurocutaneous Syndrome Committee. 50-1 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Ishikawa H, Ohnishi K, Ishikawa O.: "Further purification of neurofibroma-derived growth-stimulating factor." Annual Report of the Ministry of Health and Welfare Neurocutaneous Syndrome Committee.(1992)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Ishikawa Ossmu: "Neurofibromaーderived fibroblastーstimulating factor in the serum of patients with neurofibromatosis(von Recklinghausen's disease)." Arch Dermatol Res. 277. 433-8 (1985)

    • Related Report
      1991 Annual Research Report
  • [Publications] Ishikawa Osamu: "A decrease in colonyーforming efficiency and lifespan of neurofibromaーderived fibroblastic cells." Connective Tissue. 23. (1992)

    • Related Report
      1991 Annual Research Report
  • [Publications] Yamakage Akio: "Assay of neurofibromaーstimulating factor(NFSF)in patient with neurofibromatosis.In:Tuberous sclerosis neurofibromatosis:epidemiology,pathophysiology,biology and management." Ishibashi Y,Hori Y編, 191-5 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] 石川 英一: "神経線維腫由来増殖因子の分離、精製厚生省特定疾患神経皮膚症候群調査研究班平成2年度報告書" 50-1 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] 石川 英一: "神経線維腫由来増殖刺激因子の検討ーその後の進捗状況ー厚生省特定疾患神経皮膚症候群調査研究班平成3年度報告書" (1992)

    • Related Report
      1991 Annual Research Report
  • [Publications] Akio Yamakage(山蔭明生): "Tuberous sclerosis and neurofibromatosis:epidemiology,pathophysiology,biology and management." Excerpta Medica, 5 (1990)

    • Related Report
      1990 Annual Research Report

URL: 

Published: 1991-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi